Andrew Feigin, MD
Enriched profileChief Medical Officer, Rho (clinical research organization) · NYU Langone Health
Andrew Feigin is Chief Medical Officer, Rho (clinical research organization) at NYU Langone Health. ClinicalTrials.gov lists 2 registered studies with this person as an investigator.
Data verified 23 Oct 2026
Overview
Updated 23 Oct 2026
Andrew S. Feigin, MD, is Chief Medical Officer, Rho (clinical research organization) at NYU Langone Health (Department of Neurology, adjunct professor per NYU faculty snippet). The public record shows 168 publications with 11,159 citations (h-index 54), centered on Neurology. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 8 companies, 5 NIH-funded awards (1998–2015).
- Top research focus: Neurology
- 2 registered trials on ClinicalTrials.gov
- Open Payments reporting from 8 companies
Generated from the cited public record · current as of 23 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
No public contact details on file. This person's NPPES record doesn't include a practice address or telephone number. Why? →
Clinical trials
Updated 23 Oct 2026
Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:
Industry payments
Updated 23 Oct 2026
8 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- UCB SAProgram year20253 payments
- Eisai Inc.Program year20252 payments
- Eisai Inc.Program year20245 payments
NIH funding
Updated 23 Oct 2026
5 NIH research awards on record, funded 1998–2015 per NIH RePORTER. The latest:
- Brain Network Imaging: A Novel Biomarker for Preclinical Huntington's Disease
Feinstein Institute for Medical Research
FY2015$288,605U01NS083173 - Brain Network Imaging: A Novel Biomarker for Preclinical Huntington's Disease
Feinstein Institute for Medical Research
FY2014$696,154U01NS083173 - Early Differential Diagnosis of Parkinsonism with Metabolic Imaging and Pattern A
Feinstein Institute for Medical Research
FY2014$541,758P50NS071675
Publications
None on file yet. We only list publications we can confidently match to this person. Why? →
Background & recognition
Updated 23 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rhoworld.com ↗
Editorial & leadership roles
journal and society appointments- Distinguished member
American Academy of Neurology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rhoworld.com ↗ - Member
American Neurological Association
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rhoworld.com ↗ - Member
Movement Disorder Society
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rhoworld.com ↗ - Member
Parkinson Study Group
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rhoworld.com ↗ - Member
Huntington Study Group
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rhoworld.com ↗ - Former Director
Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, NYU Langone Health
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rhoworld.com ↗
Secondary affiliations
appointments beyond the home institution- Adjunct Professor
Department of Neurology, NYU Langone Health
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →med.nyu.edu ↗ - Director
Huntington's Disease Society of America Center of Excellence, North Shore University Hospital (Feinstein Institute)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →rhoworld.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Gareth Morgan, MD
NYU Langone Health
Nathan Levin, MD
NYU Langone Health
Ira Jacobson, MD
NYU Langone Health
Michael Zelefsky, MD
NYU Langone Health
Bruce Miller, MD
University of California, San Francisco (UCSF)
Brett Kissela, MD
Medical College of Wisconsin
Bradley Boeve, MD
Mayo Clinic
Richard Lipton, MD
Albert Einstein College of Medicine